Skip to content

Preview

In focus: A look-ahead to 2025

Global equity investors should find further opportunities to bolster portfolios in 2025, with sectors such as health care and energy looking attractive due to favorable valuations. In addition, policy easing by major central banks and a potentially business-friendly US presidency bode well for the outlook.

However, investors may have to navigate the headwinds from US tariff hikes, global trade disruptions and geopolitical conflicts, among other risks. Capturing alpha in this environment will be a test of price discipline and stock selection expertise.

Investment outlook

In North America, we expect solid growth globally in 2025, with the United States again leading. The consumer is in good shape and business optimism is high, especially in the United States. The Republicans’ aggressive agenda to spur growth through deregulation and tax cuts should support good earnings growth for companies, especially for cyclicals and likely also for small caps in the United States. Of course, some of this optimism is baked into the market, given recent stock performance and current valuations, but we believe there may be more to go.  

In Asia, APAC equities should see further earnings growth in 2025, in our view, as the recovery from the doldrums of 2023 continues. However, US policy risks cloud the regional outlook, with tariff hikes and trade disruptions having a potentially outsized impact on Asia’s exporting economies. We believe the information technology sector in Taiwan and South Korea is particularly vulnerable due to significant revenue exposure to the US market. A range of Chinese and Hong Kong firms in the consumer and pharmaceutical sectors may face increased headwinds as well. Overall, expectations for regional earnings currently point to growth of around 5% in 2025, compared to the 20% estimated for 2024.1

In Europe, we remain cautiously positive on European equities in early 2025. Although 2024 was a challenging year for thematic equities outside of the Magnificent Seven, expectations now look very low, and we think fundamentals should drive stocks from here. Economic growth may continue to underwhelm in Europe, but should the US and China economies hold up, we expect incremental improvements. While election outcomes influenced 2024 market moves, we expect fundamentals to play a greater role in 2025.   

Market review: December 2024

In December, Global equities collectively delivered a negative return in US-dollar terms, as eight out of the 11 global equity sectors retreated. In US-dollar terms, emerging market equities outperformed developed market equities, while global growth stocks significantly outperformed global value stocks.

Signals from the Fed that it intends to be cautious about further rate cuts helped drive global equities collectively lower in December 2024. Additionally, investors outside the United States were concerned about President-elect Donald Trump’s tariff plans and their implications on global trade. On the economic front, global manufacturing activity contracted in December after stabilizing in November, while flash reports for December showed that services activity remained strong in many regions.

Endnote

  1. Source: Bloomberg. January 7, 2025. Based on the MSCI AC Asia Pacific Index.
     

WHAT ARE THE RISKS?

All investments involve risks, including possible loss of principal.

Equity securities are subject to price fluctuation and possible loss of principal. Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks. There can be no assurance that multi-factor stock selection process will enhance performance. Exposure to such investment factors may detract from performance in some market environments, perhaps for extended periods.

Active management does not ensure gains or protect against market declines.

International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets. Investments in companies in a specific country or region may experience greater volatility than those that are more broadly diversified geographically. The government’s participation in the economy is still high and, therefore, investments in China will be subject to larger regulatory risk levels compared to many other countries. There are special risks associated with investments in China, Hong Kong and Taiwan, including less liquidity, expropriation, confiscatory taxation, international trade tensions, nationalization, and exchange control regulations and rapid inflation, all of which can negatively impact the fund. Investments in Taiwan could be adversely affected by its political and economic relationship with China.

Investments in fast-growing industries like the technology sector (which historically has been volatile) could result in increased price fluctuation, especially over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new drugs and medical instruments.

Diversification does not guarantee a profit or protect against a loss.

Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.